Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery

Stopped Study halted prematurely due to a change in the standard of care treatment

Conditions

• Metastatic Melanoma
• Brain Metastases

Interventions

• DRUG: Ipilimumab
• PROCEDURE: Stereotactic Radiosurgery

Sponsor

University of Michigan Rogel Cancer Center